Escheriosomes show promise in a variety of medical applications including cancer therapy, vaccine delivery, and bacterial infection treatment. Protheragen-ING specializes in cutting-edge solutions in the field of liposomal drug delivery systems, with a particular focus on escheriosomes.
Our team of experts combines scientific excellence with innovative thinking to provide a comprehensive service tailored to meet your specific needs. Whether you are looking for help with the development, formulation, optimization, or scale-up of your escheriosomes product, we will support you throughout the process.
Escheriosomes are liposomes prepared from polar lipids extracted from Escherichia coli (E. coli). Essentially, they are tiny vesicles composed of a lipid bilayer. They are unique in their ability to mimic the surface properties of E. coli bacteria.
Escheriosomes are a fascinating development in the field of drug delivery. These artificial vesicles are designed to carry drugs or other therapeutic agents that utilize the natural adhesive properties of E. coli bacteria to target specific cells or tissues in the body. This targeting mechanism could increase the efficiency and precision of drug delivery, potentially reducing side effects and improving therapeutic outcomes.
We offer strategic consulting services to help you identify the most promising avenues for escheriosome-based drug delivery solutions. Our experts will work closely with you to develop a customized strategy based on your unique requirements and objectives.
Leveraging our in-depth knowledge of lipid-based drug delivery systems, we assist in the development of optimized escheriosome formulations. Our formulation experts use state-of-the-art technology to improve drug encapsulation efficiency, stability, and bioavailability.
We offer comprehensive characterization and analytical services to evaluate the physicochemical properties of excipient formulations. Our advanced analytical methods ensure accurate determination of particle size, zeta potential, drug loading, and release kinetics.
Our team helps streamline the optimization and scale-up process for escheriosome-based products, ensuring a seamless transition from lab-scale to commercial production. We use Quality by Design (QbD) principles to optimize key formulation parameters and manufacturing processes.
We provide regulatory support services to facilitate the development and regulatory approval of escheriosome-based products. Our regulatory affairs experts guide compliance with relevant regulations and assist in the preparation of regulatory submissions.
Our team is dedicated to providing customized solutions based on your specific needs and objectives.
Contact us today to learn more about our escheriosomes services and how we can help accelerate your development program and unlock the potential of escheriosomes-based drug delivery solutions.
Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed